Background: Spinal cord injury (SCI) related bradycardia occurs frequently in patients with high cervical spine injuries. In patients with SCI-related symptomatic bradycardia, a variety of agents have been used to improve heart rate and reduce the need for vasopressor therapy. The literature concerning the use of theophylline in this disease state is sparse. Objective: The primary objective of this study was to evaluate and describe the use of theophylline for SCI-related symptomatic bradycardia. Methods: This was a retrospective case series of patients with SCI-related symptomatic bradycardia who were treated with theophylline. Patients were evaluated based on clinical response to theophylline. Patients were classified as a responder if vasopressors were discontinued or the number of bradycardia episodes decreased following the initiation of theophylline. Results: A total of twenty-six patients were included in the study. 17 (65.4%) patients were classified as responders, 5 (19.2%) patients were classified as non-responders, and 4 (15.4%) of patients were classified as undetermined. 11 patients (43.31%) were discharged on theophylline with 7 of these patients (41.2%) classified as responders. There were no significant differences between those classified as responders and those who were not. Conclusion and Relevance: This case series suggest that theophylline could be used as adjunctive therapy in patients with bradycardia secondary to acute SCI who achieve an adequate response to theophylline.
SadakaFNaydenovPonzilloSKJJPonzilloJJ. Theophylline for bradycardia secondary to cervical spinal cord injury. Neurocritical Care. 2010;13(3):389–392.
2.
Ruiz-ArangoAFRobinsonSharmaVJBGKSharmaGK. Characteristics of patients with cervical spinal injury requiring permanent pacemaker implantation. Cardiol Rev. 2006;14(4):e8–e11.
3.
LehmannKGLaneJGPiepmeierJMBatsfordWP. Cardiovascular abnormalities accompanying acute spinal cord injury in humans: incidence, time course and severity. J Am Coll Cardiol. 1987;10(1):46–52.
4.
BuntenDCWarnerALBrunnemannSRSegalJL. Heart rate variability is altered following spinal cord injury. Clin Auton Res. 1998;8(6):329–334.
5.
PiepmeierJMLehmannLaneKBJGLaneJG. Cardiovascular instability following acute cervical spinal cord trauma. Cent Nerv Syst Trauma. 1985;2(3):153–160.
6.
JiaXKowalskiRGSciubbaDMGeocadinRG. Critical care of traumatic spinal cord injury. J Intensive Care Med. 2013;28(1):12–23.
7.
WoodGCBoucherABJohnsonJLWisniewskiJNMagnottiLJCroceMA, et al.Effectiveness of pseudoephedrine as adjunctive therapy for neurogenic shock after acute spinal cord injury: a case series. Pharmacotherapy. 2014;34(1):89–93.
8.
MaderTJBertoletBOrnatoJPGuttermanJM. Aminophylline in the treatment of atropine-resistant bradyasystole. Resuscitation. 2000;47(2):105–112.
9.
MaderTJSmithlineHADurkinLScriverG. A randomized controlled trial of intravenous aminophylline for atropine-resistant out-of-hospital asystolic cardiac arrest. Acad Emerg Med2003;10(3):192-197.
10.
MaderTJSmithlineHAGibsonP. Aminophylline in undifferentiated out-of-hospital asystolic cardiac arrest. Resuscitation. 1999;41(1):39–45.
11.
MaderTJGibsonP. Adenosine receptor antagonism in refractory asystolic cardiac arrest: results of a human pilot study. Resuscitation. 1997;35(1):3–7.
12.
Schulz-StübnerS. The use of small-dose theophylline for the treatment of bradycardia in patients with spinal cord injury. Anesth Analg. 2005;101(6):1809-1811.
13.
HarrisPATaylorRThielkeRPayneJGonzalezNCondeJG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377–381.
14.
HarrisPATaylorRMinorBLElliottVFernandezMO'NealL, et al.The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
15.
BlackbournJSunderlandVB. Impact of pharmacist intervention on oral theophylline therapy in adult inpatients. Drug Intell Clin Pharm. 1987;21:811–816.
16.
StuhecM. Solifenacin-induced delirium and hallucinations. Gen Hosp Psychiatr. 2013;35(6):682.e3–4.
